Transcriptomic Profiling of Thyroid Eye Disease Orbital Fibroblasts Identifies Sorafenib as a Novel Therapeutic
Kyle Yuan, Phillip Truong, Charkira Patrick…·Collynn F. Woeller
This study identifies sorafenib as a potential therapeutic for thyroid eye disease by analyzing transcriptomic changes in orbital fibroblasts and validating its effects on key pathways.